|
1
|
A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition.
|
Genes Dev
|
2008
|
3.85
|
|
2
|
The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
|
Oncogene
|
2005
|
3.01
|
|
3
|
The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer.
|
Nat Med
|
2004
|
2.11
|
|
4
|
Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers.
|
Biochem Biophys Res Commun
|
2002
|
2.09
|
|
5
|
Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy.
|
Oncogene
|
2002
|
2.09
|
|
6
|
E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations.
|
Hum Mol Genet
|
2005
|
1.95
|
|
7
|
The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas.
|
Int J Cancer
|
2006
|
1.91
|
|
8
|
Deregulated expression of miR-106a predicts survival in human colon cancer patients.
|
Genes Chromosomes Cancer
|
2008
|
1.75
|
|
9
|
Intratumoral heterogeneity in microsatellite alterations in BRCA1 and PTEN regions in sporadic colorectal cancer.
|
Ann Surg Oncol
|
2003
|
1.45
|
|
10
|
The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation.
|
J Biol Chem
|
2009
|
1.35
|
|
11
|
Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched.
|
RNA
|
2008
|
1.35
|
|
12
|
The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells.
|
Carcinogenesis
|
2007
|
1.27
|
|
13
|
MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells.
|
Hum Mol Genet
|
2012
|
1.26
|
|
14
|
Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.
|
Clin Cancer Res
|
2006
|
1.23
|
|
15
|
Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer.
|
Carcinogenesis
|
2009
|
1.20
|
|
16
|
Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells.
|
J Clin Invest
|
2009
|
1.19
|
|
17
|
Thyroid hormone receptors/THR genes in human cancer.
|
Cancer Lett
|
2003
|
1.17
|
|
18
|
Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer.
|
Oncogene
|
2002
|
1.15
|
|
19
|
Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients.
|
Cancer Sci
|
2013
|
1.14
|
|
20
|
In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion.
|
Mol Cell Proteomics
|
2013
|
1.11
|
|
21
|
KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells.
|
Hum Mol Genet
|
2011
|
1.10
|
|
22
|
Free circulating mRNA in plasma from breast cancer patients and clinical outcome.
|
Cancer Lett
|
2008
|
1.09
|
|
23
|
Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients.
|
Breast Cancer Res
|
2007
|
1.07
|
|
24
|
Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature.
|
Clin Cancer Res
|
2013
|
1.07
|
|
25
|
Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms.
|
J Pathol
|
2003
|
1.05
|
|
26
|
Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors.
|
Mutat Res
|
2003
|
1.04
|
|
27
|
p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis.
|
Int J Cancer
|
2008
|
1.01
|
|
28
|
The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression.
|
J Steroid Biochem Mol Biol
|
2010
|
1.01
|
|
29
|
FGFR4 role in epithelial-mesenchymal transition and its therapeutic value in colorectal cancer.
|
PLoS One
|
2013
|
0.97
|
|
30
|
The carotenoid beta-cryptoxanthin stimulates the repair of DNA oxidation damage in addition to acting as an antioxidant in human cells.
|
Carcinogenesis
|
2008
|
0.94
|
|
31
|
Protumorigenic effects of Snail-expression fibroblasts on colon cancer cells.
|
Int J Cancer
|
2013
|
0.93
|
|
32
|
Different exosome cargo from plasma/bronchoalveolar lavage in non-small-cell lung cancer.
|
Genes Chromosomes Cancer
|
2014
|
0.89
|
|
33
|
Prognostic impact of ΔTAp73 isoform levels and their target genes in colon cancer patients.
|
Clin Cancer Res
|
2011
|
0.88
|
|
34
|
Tumor-derived exosomes are enriched in ΔNp73, which promotes oncogenic potential in acceptor cells and correlates with patient survival.
|
Hum Mol Genet
|
2013
|
0.88
|
|
35
|
Genomic profiling of circulating plasma RNA for the analysis of cancer.
|
Clin Chem
|
2007
|
0.88
|
|
36
|
Thymidylate synthase messenger RNA expression in plasma from patients with colon cancer: prognostic potential.
|
Clin Cancer Res
|
2006
|
0.86
|
|
37
|
The GADD45, ZBRK1 and BRCA1 pathway: quantitative analysis of mRNA expression in colon carcinomas.
|
J Pathol
|
2005
|
0.85
|
|
38
|
Altered expression of the ZBRK1 gene in human breast carcinomas.
|
J Pathol
|
2004
|
0.84
|
|
39
|
The TP73 complex network: ready for clinical translation in cancer?
|
Genes Chromosomes Cancer
|
2013
|
0.83
|
|
40
|
The effects of 1,25-dihydroxyvitamin D3 on colon cancer cells depend on RhoA-ROCK-p38MAPK-MSK signaling.
|
J Steroid Biochem Mol Biol
|
2010
|
0.82
|
|
41
|
A prospective study of left ventricle function after treatment with rapid-infusion rituximab in patients with non-Hodgkin lymphoma.
|
Leuk Lymphoma
|
2009
|
0.81
|
|
42
|
RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma.
|
Genes Chromosomes Cancer
|
2002
|
0.81
|
|
43
|
Prognostic value of LISCH7 mRNA in plasma and tumor of colon cancer patients.
|
Clin Cancer Res
|
2007
|
0.81
|
|
44
|
Analysis of competing risks of causes of death and their variation over different time periods in Hodgkin's disease.
|
Clin Cancer Res
|
2008
|
0.80
|
|
45
|
Prognostic factors in Hodgkin's disease.
|
Leuk Lymphoma
|
2004
|
0.78
|
|
46
|
Differential regulation of TP73 isoforms by 1α,25-dihydroxyvitamin D3 and survivin in human colon and breast carcinomas.
|
Genes Chromosomes Cancer
|
2010
|
0.78
|
|
47
|
Differential genetic and functional markers of second neoplasias in Hodgkin's disease patients.
|
Clin Cancer Res
|
2009
|
0.77
|
|
48
|
Analysis of the candidate tumor suppressor Ris-1 in primary human breast carcinomas.
|
Mutat Res
|
2005
|
0.76
|
|
49
|
Association between hepatitis C virus and non-Hodgkin's lymphomas.
|
J Clin Oncol
|
2006
|
0.75
|
|
50
|
Natural progression of embryonal carcinoma.
|
Arch Esp Urol
|
2010
|
0.75
|
|
51
|
The procedures for assessing oncological research in Spain.
|
Clin Transl Oncol
|
2006
|
0.75
|
|
52
|
The management of stage I-II supradiaphragmatic Hodgkin's disease with chemotherapy alone.
|
Leuk Lymphoma
|
2003
|
0.75
|